The US Food and Drug Administration (FDA) has notified Bayer that it has extended the review period for the New Drug ...

US pharma major Bristol Myers Squibb revealed it has appointed Dr Cristian Massacesi as executive vice president, chief ...

Swiss pharma major Novartis (NOVN: VX) has entered into an exclusive option and license deal with Matchpoint Therapeutics to ...

It has been a stellar week for Abivax, a French biotech developing therapeutics that harness the body’s natural regulatory ...

Privately-held Swiss biotech Memo Therapeutics has announced results from its Phase II trial evaluating potravitug, a ...

TCG Labs Soleil has secured another $400 million to expand its global R&D footprint and help build out its growing portfolio ...

The Trump administration has asked the US Supreme Court to allow the National Institutes of Health (NIH) to resume canceling ...

Semaglutide, a GLP-1R agonist developed by Denmark’s Novo Nordisk as Ozempic, initially for type 2 diabetes, and marketed ...

Chief executive Thomas Schinecker believes the price of drugs in the USA could be lowered considerably if this model were ...

The European Medicines’ (EMA) human medicines committee (CHMP) has recommended seven novel medicines for approval at its July ...

French drugmaker Ipsen announced that the European Commission (EC) has approved Cabometyx (cabozantinib) for adult patients ...

In an import contrast to events in the USA, UK pharma major GSK late Thursday announced the approval of Blenrep (belantamab ...